Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rocket Pharmaceuticals (RCKT) Goodwill & Intangibles: 2018-2024

Historic Goodwill & Intangibles for Rocket Pharmaceuticals (RCKT) over the last 7 years, with Dec 2024 value amounting to $64.3 million.

  • Rocket Pharmaceuticals' Goodwill & Intangibles changed negligibly% to $64.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $64.3 million, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $64.3 million for FY2024, which is negligibly% changed negligibly from last year.
  • According to the latest figures from FY2024, Rocket Pharmaceuticals' Goodwill & Intangibles is $64.3 million, which was down 0.00% from $64.3 million recorded in FY2023.
  • Over the past 5 years, Rocket Pharmaceuticals' Goodwill & Intangibles peaked at $64.9 million during FY2022, and registered a low of $30.8 million during FY2020.
  • In the last 3 years, Rocket Pharmaceuticals' Goodwill & Intangibles had a median value of $64.3 million in 2024 and averaged $64.5 million.
  • Per our database at Business Quant, Rocket Pharmaceuticals' Goodwill & Intangibles surged by 110.69% in 2022 and then fell by 0.88% in 2023.
  • Over the past 5 years, Rocket Pharmaceuticals' Goodwill & Intangibles (Yearly) stood at $30.8 million in 2020, then remained steady at $30.8 million in 2021, then soared by 110.69% to $64.9 million in 2022, then decreased by 0.88% to $64.3 million in 2023, then remained steady at $64.3 million in 2024.